News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Roche Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development     12/19/2014
Merck & Co.'s Keytruda Shrank Tumors In Hard-To-Treat Breast Cancer Patients     12/11/2014
Analysts Not Sold On Medivation, Inc.’s Xtandi as Breast Cancer Drug     12/10/2014
Novartis AG Copy Of Amgen Cancer Drug Shows Similar Efficacy     12/8/2014
Puma Biotechnology Sinks On Breast Cancer Drug NDA Delay     12/4/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Merrion Pharmaceuticals, Inc. Bids To Attract €52m Investment For Products     12/1/2014
Best Value In Biotech? Actavis, Says UBS     11/17/2014
Roche, Merck & Co. Extend Immunotherapy Battle To Breast Cancer     10/17/2014
Pfizer's Palbociclib Granted FDA Priority Review     10/14/2014
Genentech's New Breast Cancer Drug Greatly Extends Survival Rates     9/30/2014
Roche’s Avastin Prolongs Life In Breast Cancer Study     9/25/2014
Another Controversial High Price Med: National Institute for Clinical Excellence (NICE) Rejects Roche's New $152,850 Breast Cancer Drug     8/11/2014
Puma Biotechnology Shares Soar On Breast Cancer Drug Results     7/28/2014
Amgen, Bayer HealthCare's Nexavar Fails Late-Stage Breast Cancer Study     7/25/2014

Featured Stories
Low-Fat Diet May Help Women Survive Breast Cancer, UCLA Medical Center Study     12/16/2014
No Link Between Migraine, Breast Cancer Risk, Harvard University Study Says     12/15/2014
A*STAR Scientists Uncover Gene Associated With An Aggressive Breast Cancer     12/2/2014
Increasing Skirt Size Boosts Your Breast Cancer Risk, University College London Study     9/26/2014
Is Soy A Foe To Women With Breast Cancer? Memorial Sloan-Kettering Cancer Center Study     9/8/2014
Bras Cause Breast Cancer? Apparently Not, Fred Hutchinson Cancer Research Center Study     9/5/2014
Study Ties New Gene Mutation To Major Breast Cancer Risk, The New England Journal of Medicine Reveals     8/7/2014
Birth Control Pills May Double Breast Cancer Risk, Fred Hutchinson Cancer Research Center Study     8/4/2014
Total Darkness During The Night Is A Key To Success Of Breast Cancer Therapy, Tulane University Study     7/28/2014
Association Found Between High Cholesterol And Breast Cancer, Aston University School Of Medical Sciences Study     7/7/2014
No Link Found Between Fertility Drugs And Cancers, University of Illinois Study     7/1/2014
Harmless Virus Kills Cancer And Tumor Cells, Pennsylvania State University Study     6/26/2014
Single Drug Could Soon Cure High Cholesterol, Breast Cancer, University of Missouri Study     6/19/2014
Red Meat Possibly Linked To Breast Cancer, Harvard School of Public Health Study     6/12/2014
Moles Linked To Breast Cancer Risk, Indiana University And Harvard University Study     6/11/2014

More News
Genentech (RHHBY) Provides Update On Phase 3 MARIANNE Study In People With Previously Untreated Advanced HER2-Positive Breast Cancer     12/19/2014
OncoGenex Pharmaceuticals Inc. (OGXI) Announces Results From The Phase 2 Borealis-1 Trial Of Apatorsen In The Treatment Of Metastatic Bladder Cancer     12/19/2014
Inovio Pharmaceuticals (INO) Initiates DNA Immunotherapy Trial For Breast, Lung And Pancreatic Cancers     12/18/2014
Phenogen Sciences, Inc. Announces Clinical Validation Study Supporting The Use Of Brevagenplus® In Breast Cancer Risk Assessment     12/17/2014
Astellas Pharma Inc. (ALPMY) Release: Data Presented From Phase 2 Study Of Enzalutamide In Advanced Androgen-Receptor Positive, Triple-Negative Breast Cancer     12/15/2014
Immunomedics, Inc. (IMMU) Reports Preliminary Results From Pretargeted Imaging Study In Patients With Metastatic Breast Cancer     12/15/2014
Immunomedics, Inc. (IMMU) Reports Expanded Phase 1/2 Trials Confirm Activity And Good Safety Profile Of Sacituzumab Govitecan (Immu-132) In Patients With Advanced Triple-Negative Breast Cancer     12/12/2014
Synta Pharmaceuticals (SNTA) Announces Presentation Of Results From An Investigator-Sponsored Phase 1 Trial Of Ganetespib In HER2+ Metastatic Breast Cancer At The 2014 San Antonio Breast Cancer Symposium     12/12/2014
Nektar Therapeutics (CA) (NKTR) Presents Data On Target-Specific Biomarkers From Circulating Tumor Cell Sub-Study Of Phase 3 BEACON Study Of Etirinotecan Pegol (NKTR-102) In Patients With Advanced Breast Cancer     12/12/2014
Oncothyreon Inc. (ONTY) Announces Presentation Of Positive ONT-380 Data At San Antonio Breast Cancer Symposium     12/12/2014
Janssen Research & Development Release: Data From The EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented At San Antonio Breast Cancer Symposium     12/12/2014
Merrimack Pharmaceuticals Inc. (MACK) Presents Research On Innovative Pipeline For Patients With Breast Cancer At The 2014 San Antonio Breast Cancer Symposium     12/12/2014
Calithera Biosciences, Inc. (CALA) Presents Novel Pharmacodynamic Assay Data Confirming Glutaminase Inhibition In Tumor Biopsy Samples From Patients Treated With CB-839     12/11/2014
Caris Life Sciences Presents Two Studies Demonstrating Utility Of Tumor Profiling: Likelihood Of Response To Immunotherapeutics In HER2-Positive Breast Cancer And The Largest Case Series Comparing Male Breast Cancer To Female Breast Cancer Patients     12/11/2014
International Breast Cancer Study Group, Breast International Group And Merck & Co. (MRK) Announce Opening Of International PANACEA Study Of Patients With HER2+ Breast Cancer     12/10/2014

//-->